Get started
Author

Olivia Watchorn

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
2021 · Hesham Abdelhady, Marwa Abdelrazik, et al. · JAMA · 215
PDF
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 146
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 143
PDF
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
2022 · Simeng Lin, Nicholas A. Kennedy, et al. · Nature Communications · 105
PDF
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
2023 · Simin  Florescu, Delia Stanciu, et al. · JAMA · 68
PDF
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
2023 · The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators, Simin  Florescu, et al. · JAMA · 59
PDF
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Jean-François Rahier, et al. · Clinical Gastroenterology and Hepatology · 42
PDF
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
2022 · Zhigang Liu, Kaixing Le, et al. · The Lancet. Gastroenterology & hepatology · 36
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study
2022 · Aurelien Amiot, Jean-Francois Rahier, et al. · Journal of Crohn s and Colitis · 18
PDF
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial
2024 · Vishal C. Patel, Mark J. McPhail, et al. · Trials · 11
PDF
Development and validation of a multivariable risk factor questionnaire to detect oesophageal cancer in 2-week wait patients
2023 · Kai Man Alexander Ho, Avi Rosenfeld, et al. · Clinics and Research in Hepatology and Gastroenterology · 4
Using Saliva Epigenetic Data to Develop and Validate a Multivariable Predictor of Esophageal Cancer Status
2024 · Timothy C Stone, Vanessa Ward, et al. · Epigenomics · 3
Works count: 12
Citation count: 850
H-index: 10
I10-index: 10
Year
Topic
Type